Home » Newsletters » BioWorld Science

BioWorld Science

April 28, 2003

View Archived Issues

Cel-Sci receives SBIR grant to develop treatment for autoimmune myocarditis

Methods of inhibiting cancer metastasis using polypeptides targeting chemokine receptors

Novel IKK-2 inhibitors prepared and tested at Pharmacia

Pyrazole-based antiproliferative agents covered by Bayer patent

Beta3-adrenoceptor agonists and their use in obesity, diabetes, etc.

Antibacterial agents with RNase-based mechanism of action discovered at Message

Mitsubishi Pharma and Sanofi-Synthelabo present new TPK1 inhibitors for AD

Novel vitamin D3 analogues with utility in osteoporosis and other disorders under study at Roche

Novo Nordisk presents new DPP-IV inhibitors

Axcan responds to Salix's rejection of cash tender offer

Serono initiates phase I trial of beta-sheet breaker peptide for Alzheimer's disease

AVI-4020 completes preclinical testing

TTS-CD2 prolongs survival in NSCLC

Tostrex rebranded Fortigel

Cypher stent approved by FDA

FavId phase II study expanded

Genesis Research and EvoGenix collaborate on antiinflammatory discovery

DCVax-Direct Adjuvant Cancer Therapy shows positive results in mice

FDA lifts clinical hold on Skeletal Targeted Radiotherapy

IND filed for phase III bromfenac studies

Positive Visicol laxative study results announced

Phase III findings for Extina in seborrheic dermatitis to support NDA filing

INGN-241 effective in ovarian cancer in preclinical study

LymphoStat-B is biologically active in patients with SLE

Drotrecogin alfa (activated) reduces mortality and organ failure in severe sepsis

The effects of sPLA2 inhibitor on the survival rate of patients with severe sepsis

Merck discontinues development of lead PDE4 inhibitor

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...